here to treat a patient with community-acquired pneumonia (CAP) is probably the most important decision in the management of this condition. This is true in terms of patient outcomes and, definitely, in terms of costs. Therefore, all current European and American guidelines agree that the assessment of severity is the starting point in the management algorithm If the assessment is so crucial, what are the criteria physicians can rely on?
No takes yet. Share an insight, caveat, or question.
Ewig et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: